Journal of Health and Medical Sciences
ISSN 2622-7258
Published: 20 December 2023
An Experimental Evidence for Antibacterial Activity of Propolis on Bacteria from Lebanese Patients
Amena Allouch, Zainab Dagher, Dr. Ali Khalil Mezher
Safir High School, Taakhi medical centre
Download Full-Text Pdf
10.31014/aior.1994.06.04.293
Pages: 199-209
Keywords: Propolis, Anti-Bacterial, Anti-Fungal, Lebanon
Abstract
Propolis, with its distinctive chemical composition, has been known for therapeutic potential in treating numerous diseases. This study investigated whether propolis has an antibacterial effect on bacteria in Lebanon. Twenty- eight samples of gram-negative and gram-positive bacteria were collected from Raii Hospital and Al-Taakhi Medical Center in Gazieh, South Lebanon. Each sample was streaked on three different Petri dishes with different percentages of propolis under aseptic conditions. The results were recorded visually and confirmed by Gram staining after incubation for 24 h at 37°C. The obtained results show that propolis inhibited the growth of 18% of the total number of collected bacteria. The majority of bacteria on which propolis had an inhibitory effect were gram- positive bacteria, which inhibited 50% of them, whereas it only inhibited the growth of 9% of the gram-negative bacteria. Propolis was also shown to have an antifungal effect.
References
Ahangari Z., Naseri M., Vatandoost F. (2018). Propolis: Chemical Composition and Its Applications in Endodontics. . Iran. Endod. J., 13:285–292.
Ahmed R., Tanvir E., Hossen M.S., Afroz R., Ahmmed I., Rumpa N.-E., Paul S., Gan S.H., Sulaiman S.A., Khalil M.I. (2017). Antioxidant properties and cardioprotective mechanism of Malaysian propolis in rats. Evidence-Based Complement. Alternat. Med.
Al-Hariri M.T. (2011). Propolis and its direct and indirect hypoglycemic effect. J. Family Commun. Med. , 18:152.
Alhassan Sa-eed, Eric S Donkor, Reuben E Arhin, Patience B Tetteh-Quarcoo, Simon K Attah, Daniel E K Kabotso, Fleischer C N Kotey, Nicholas T K D Dayie. (2023). In vitro antimicrobial activity of crude propolis extracts and fractions. FEMS Microbes, 4 https://doi.org/10.1093/femsmc/xtad010
Almuhayawi, M.S. (2020). Propolis as a novel antibacterial agent. Saudi J. Biol. Sci. 27, 3079–3086
Aminimoghadamfarouj N. & Nematollahi A. (2017). Propolis diterpenes as a remarkable bio-source for drug discovery development: a review. Int. J. Mol. Sci., 18:1290.
Ansorge S., Reinhold D., Lendeckel U. (2003). Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-Beta1 production of human immune cells. Naturforsch., 58:580–589. https://doi.org/10.1515/znc-2003-7-82
Araujo M.A., Libério S.A., Guerra R.N., Ribeiro M.N.S., Nascimento F.R. (2012). mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: A brief review. Rev. Bras. Farmacogn. , 22:208–219. https://doi.org/10.1590/S0102-695X201100500
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis, 6(2), 71–79. https://doi.org/10.1016/j.jpha.2015.11.005
Bouchelaghem S. (2022). Propolis characterization and antimicrobial activities against Staphylococcus aureus and Candida albicans: A review. Saudi Journal of Biological Sciences., 29(4):1936–1946. https://doi.org/10.1016/j.sjbs.2021.11.063
Bratko, Filipic & Gradisnik, Lidija & Gregorič, Dunja & Pereyra, Adriana & Ružić-Sabljić, Eva & Mazija, Hrvoje. (2020). The polyphenol content and antimicrobial activity of selected propolis' extracts. Journal of Agriculture Science & Technology. 10. 350-364. https://doi.org/10.17265/2161-6264/2020.06.004
Burdock GA. (1998). Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology., 36(4):347–363.
Chamoun, K., Farah, M., Araj, G., Daoud, Z., Moghnieh, R., Salameh, P., Saade, D., Mokhbat, J., Abboud, E., Hamze, M., Abboud, E., Jisr, T., Haddad, A., Feghali, R., Azar, N., El-Zaatari, M., Chedid, M., Haddad, C., Zouain Dib Nehme, M., Barakat, A., … (2016). Lebanese Society of Infectious Diseases Study Group (L)SID study group). Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, 46, 64–70. https://doi.org/10.1016/j.ijid.2016.03.010
Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. (2012). The Impact of the Gut Microbiota on Human Health: An Integrative View. . Cell. , 148:1258–1270. https:// doi.org/10.1016/j.cell.2012.01.035.
Cornara L., Biagi M., Xiao J., Burlando B.;. (2017). Therapeutic properties of bioactive compounds from different honeybee products. Front. Pharmacol., ;8:412. https://doi.org/10.3389/fphar.2017.00412.
D'Auria, F. D., Tecca, M., Scazzocchio, F., Renzini, V., & Strippoli, V. (2003). Effect of propolis on virulence factors of Candida albicans. Journal of chemotherapy (Florence, Italy), 15(5), 454–460. https://doi.org/10.1179/joc.2003.15.5.454
De Castro SL. (2001). Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Annual Review of Biomedical Sciences. , 3:49–83.
Gómez-Caravaca A.M., Gómez-Romero M., Arráez-Román D., Segura-Carretero A., Fernández-Gutiérrez A. (2006). Advances in the analysis of phenolic compounds in products derived from bees. J. Pharmac. Biomed. Anal. , 41:1220–1234. https://doi.org/10.1016/j.jpba.2006.03.002.
Gucwa, K., Kusznierewicz, B., Milewski, S., Van Dijck, P., & Szweda, P. (2018). Antifungal Activity and Synergism with Azoles of Polish Propolis. Pathogens (Basel, Switzerland), 7(2), 56. https://doi.org/10.3390/pathogens7020056
Hamzé, M., Osman, M., Mallat, H., & Raad, E.B. (2017). Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North of Lebanon. The International Arabic Journal of Antimicrobial Agents, 7.
Hausen BM, Wollenweber E, Senff H, Post B. Propolis allergy. (1987). The sensitizing properties of 1,1-dimethylallyl caffeic acid ester. Contact Dermatitis , 17(3):171–177.
Kim Y. H. & C. H. J. (2011). The effects of Korean propolis against foodborne pathogens and transmission electron microscopic examination. New biotechnology, 28(6):713–718. https://doi.org/10.1016/j.nbt.2010.12.006.
Khodor, M., Hamzé, M., Mallat, H., Chahine, Z., Chalouhi, G., Achkar, M., & Azar, N. (2022). Co-infection in patients with COVID-19 in Tripoli Northern Lebanon: germs involved and antibiotic sensitivity profile. The International Arabic Journal of Antimicrobial Agents.
Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. (1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. . Journal of Ethnopharmacology, 64(3):235–240.
Kumar N, Ahmad MKK, Dang R, Husain A. . (2008). Antioxidant and antimicrobial activity of propolis from Tamil Nadu zone. . Journal of Medicinal Plants Research. , 2(12):361–364. .
Manso, T., Lores, M., & de Miguel, T. (2021). Antimicrobial Activity of Polyphenols and Natural Polyphenolic Extracts on Clinical Isolates. Antibiotics (Basel, Switzerland), 11(1), 46. https://doi.org/10.3390/antibiotics11010046
Marcucci M. (1995). Propolis: chemical composition, biological properties and therapeutic activity. Apidologie. , 26(2):83–99.
Mutlu Sariguzel, F.; Berk, E.; Koc, A.N.; Sav, H.; Demir, G. (2016) Antifungal activity of Propolis against yeasts isolated from blood culture: In vitro evaluation. J. Clin. Lab. Anal., 30, 513–516.).
Özcan M. (1999). Antifungal properties of propolis. Grasas Aceites., 50:395–398.
Ożarowski, M., Karpiński, T. M., Alam, R., & Łochyńska, M. (2022). Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions. Microorganisms, 10(2),364. https://doi.org/10.3390/microorganisms10020364
Pimenta, H. C., Violante, I. M., Musis, C. R., Borges, Á. H., & Aranha, A. M. (2015). In vitro effectiveness of Brazilian brown propolis against Enterococcus faecalis. Brazilian oral research, 29, https://doi.org/10.1590/1807-3107BOR-2015.vol29.0058
Przybyłek, I., & Karpiński, T. M. (2019). Antibacterial Properties of Propolis. Molecules (Basel, Switzerland), 24(11), 2047. https://doi.org/10.3390/molecules24112047
Ristivojević P, Dimkić I, Guzelmeric E, Trifković J, Knežević M, Berić T, Yesilada E, Milojković-Opsenica D, Stanković S. (2018). Profiling of Turkish propolis subtypes: Comparative evaluation of their phytochemical compositions, antioxidant and antimicrobial activities. LWT, 95:367–379. https://doi.org/10.1016/j.lwt.2018.04.063.
Sikkema J., de Bont J. A., Poolman B. (1995). Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 59, 201–222.
Silva-Carvalho, R.; Baltazar, F.; Almeida-Aguiar, C. (2015). Propolis: A complex natural product with a plethora of biological activities that can be explored for drug
development. Evid. Based Complement. Altern. Med.
Touzani, S., Imtara, H., Katekhaye, S., Mechchate, H., Ouassou, H., Alqahtani, A. S., Noman, O. M., Nasr, F. A., Fearnley, H., Fearnley, J., Paradkar, A., ElArabi, I., & Lyoussi, B. (2021). Determination of Phenolic Compounds in Various Propolis Samples Collected from an African and an Asian Region and Their Impact on Antioxidant and Antibacterial Activities. Molecules (Basel, Switzerland), 26(15), 4589. https://doi.org/10.3390/molecules26154589
Uzel, A.; Önçağ, Ö.; Çoğulu, D.; Gençay, Ö. (2005). Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol. Res. 2005, 160, 189–195.
Wagh V. D. (2013). Propolis: a wonder bees product and its pharmacological potentials. Advances in pharmacological sciences, 308249. https://doi.org/10.1155/2013/308249.
Zhang X., Wang G., Gurley E.C., & Zhou H. (2014). Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS ONE. , 9:e107072. https://doi.org/10.1371/journal.pone.0107072.